Epigenetic Mechanisms and Events in Gastric Cancer-Emerging Novel Biomarkers

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Pathology and Oncology Research

• Publication date

  2018-03-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12253-018-0410-zPMID 29552712
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epigenetics mechanisms mediate the miR-125a/BRMS1 axis to regulate invasion and metastasis in gastric cancer

  2019cited by this paper
• Current Understanding of Circular RNAs in Gastric Cancer

  2019cited by this paper
• Recent advances in gastric cancer early diagnosis

  2019cited by this paper
• Integrated analysis of long non-coding RNA competing interactions reveals the potential role in progression of human gastric cancer.

  2016cited by this paper
• Non-coding RNAs as emerging molecular targets of gallbladder cancer.

  2016cited by this paper
• DNA Methylation mediated down-regulating of MicroRNA-33b and its role in gastric cancer

  2016cited by this paper
• High-definition CpG methylation of novel genes in gastric carcinogenesis identified by next-generation sequencing

  2016cited by this paper
• Dysregulation of non-coding RNAs in gastric cancer.

  2015cited by this paper
• Identification of the long non-coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer

  2015cited by this paper
• Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients.

  2015cited by this paper
• Epigenetics: an emerging player in gastric cancer.

  2014cited by this paper
• Role of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: a clinical and in vitro investigation.

  2014cited by this paper
• Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer

  2014cited by this paper
• Enhanced Expression of Long Non-Coding RNA HOTAIR Is Associated with the Development of Gastric Cancer

  2013cited by this paper
• Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel

  2013cited by this paper
• Gene methylation in gastric cancer.

  2013cited by this paper
• MicroRNA-195 and microRNA-378 mediate tumor growth suppression by epigenetical regulation in gastric cancer.

  2013cited by this paper
• Analysis of long non-coding RNA expression profiles in gastric cancer.

  2013cited by this paper
• Epigenetic Silencing of miR-338-3p Contributes to Tumorigenicity in Gastric Cancer by Targeting SSX2IP

  2013cited by this paper
• microRNA-449a functions as a tumor-suppressor in gastric adenocarcinoma by targeting Bcl-2

  2013cited by this paper
• Circulating long non-coding RNAs in plasma of patients with gastric cancer.

  2013cited by this paper
• miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP

  2012cited by this paper
• microRNA-155 is downregulated in gastric cancer cells and involved in cell metastasis.

  2012cited by this paper
• Landscape of transcription in human cells

  2012cited by this paper
• Upregulation of miR-196a and HOTAIR drive malignant character in gastrointestinal stromal tumors.

  2012cited by this paper
• DNA methylation and microRNA dysregulation in cancer

  2012cited by this paper
• miR-137 Is Frequently Down-Regulated in Gastric Cancer and Is a Negative Regulator of Cdc42

  2011cited by this paper
• Non-coding RNAs in human disease

  2011cited by this paper
• Aberrant hypermethylation of miR-9 genes in gastric cancer

  2011cited by this paper
• MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2

  2010cited by this paper
• Epigenetics and human disease.

  2009cited by this paper
• Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer.

  2009cited by this paper
• Recent advances in conventional and molecular prognostic factors for gastric carcinoma.

  2008cited by this paper
• DNA methylation: a marker for carcinogen exposure and cancer risk

  2008cited by this paper
• Gene silencing of TSPYL5 mediated by aberrant promoter methylation in gastric cancers

  2008cited by this paper
• The Global Histone Modification Pattern Correlates with Cancer Recurrence and Overall Survival in Gastric Adenocarcinoma

  2008cited by this paper
• Promoter methylation of cancer-related genes in gastric carcinoma.

  2008cited by this paper
• Epigenetic biomarkers for human cancer: the time is now.

  2008cited by this paper
• Methylation status of ANAPC1, CDKN2A and TP53 promoter genes in individuals with gastric cancer.

  2008cited by this paper
• Breast cancer epigenetics: normal human mammary epithelial cells as a model system

  2008cited by this paper
• Helicobacter pylori regulates p21(WAF1) by histone H4 acetylation.

  2008cited by this paper
• Cytogenetic and molecular aspects of gastric cancer: clinical implications.

  2008cited by this paper
• Histone deacetylase inhibitors—turning epigenic mechanisms of gene regulation into tools of therapeutic intervention in malignant and other diseases

  2007cited by this paper
• Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer

  2007cited by this paper
• Interrelationships among chromosome aneuploidy, promoter hypermethylation, and protein expression of the CDKN2A gene in individuals from northern Brazil with gastric adenocarcinoma.

  2007cited by this paper
• [Correlation of E-cadherin hypermethylation to tumorigenesis and development of gastric cancer].

  2007cited by this paper
• Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer

  2007cited by this paper
• Micro‐RNAs as Oncogenes and Tumour Suppressors

  2007cited by this paper
• PRDM5 Identified as a Target of Epigenetic Silencing in Colorectal and Gastric Cancer

  2007cited by this paper
• Frequent loss of Brm expression in gastric cancer correlates with histologic features and differentiation state.

  2007cited by this paper
• Frequent epigenetic inactivation of hSRBC in gastric cancer and its implication in attenuated p53 response to stresses

  2007cited by this paper
• Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer.

  2007cited by this paper
• Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors.

  2007cited by this paper
• Pathogenesis and treatment of gastric carcinoma: "an up-date with brief review".

  2006cited by this paper
• Cellular and molecular aspects of gastric cancer.

  2006cited by this paper
• Role of epigenetic alterations in cholangiocarcinoma.

  2006cited by this paper
• Genomic loss and epigenetic silencing of very-low-density lipoprotein receptor involved in gastric carcinogenesis

  2006cited by this paper
• E-cadherin in gastric cancer.

  2006cited by this paper
• MicroRNA signatures in human cancers

  2006cited by this paper
• Histone deacetylase inhibitor, trichostatin A, increases the chemosensitivity of anticancer drugs in gastric cancer cell lines.

  2006cited by this paper
• Polycomb silencers control cell fate, development and cancer

  2006cited by this paper
• The significance of aberrant CHFR methylation for clinical response to microtubule inhibitors in gastric cancer

  2006cited by this paper
• CDH1 Gene Promoter Hypermethylation in Gastric Cancer: Relationship to Goseki Grading, Microsatellite Instability Status, and EBV Invasion

  2006cited by this paper
• MicroRNAs as oncogenes and tumor suppressors.

  2005cited by this paper
• DNA methylation and human disease

  2005cited by this paper
• Approval Summary: Azacitidine for Treatment of Myelodysplastic Syndrome Subtypes

  2005cited by this paper
• Phase II study of low-dose decitabine in patients with chronic myelogenous leukemia resistant to imatinib mesylate.

  2005cited by this paper
• Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma.

  2005cited by this paper
• Histone H3 acetylation is associated with reduced p21WAF1/CIP1 expression by gastric carcinoma

  2005cited by this paper
• Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in gastrointestinal tumour

  2005cited by this paper
• The Transcriptional Landscape of the Mammalian Genome

  2005cited by this paper
• A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes

  2005cited by this paper
• Promoter hypermethylation of Death-associated protein-kinase gene associated with advance stage gastric cancer.

  2005cited by this paper
• Loss of caspase-1 gene expression in human gastric carcinomas and cell lines.

  2005cited by this paper
• Prognostic Analysis of E-Cadherin Gene Promoter Hypermethylation in Patients with Surgically Resected, Node-Positive, Diffuse Gastric Cancer

  2004cited by this paper
• AKAP12/Gravin is inactivated by epigenetic mechanism in human gastric carcinoma and shows growth suppressor activity

  2004cited by this paper
• Epigenetic alterations in head and neck cancer: Prevalence, clinical significance, and implications

  2004cited by this paper
• Demethylation of the synuclein gamma gene CpG island in primary gastric cancers and gastric cancer cell lines.

  2004cited by this paper
• Frequent CpG island methylation in precursor lesions and early gastric adenocarcinomas

  2004cited by this paper
• Frequent epigenetic inactivation of RIZ1 by promoter hypermethylation in human gastric carcinoma

  2004cited by this paper
• Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma

  2004cited by this paper
• Demethylation of MAGE promoters during gastric cancer progression

  2004cited by this paper
• Focus on gastric cancer.

  2004cited by this paper
• Genetic pathways of two types of gastric cancer.

  2004cited by this paper
• A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin.

  2004cited by this paper
• Polycomb complexes and silencing mechanisms.

  2004cited by this paper
• Demethylation of the Synuclein γ Gene CpG Island in Primary Gastric Cancers and Gastric Cancer Cell Lines

  2004cited by this paper
• Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells

  2003cited by this paper
• Loss of beta-catenin expression in metastatic gastric cancer.

  2003cited by this paper
• Profile of Aberrant CpG Island Methylation along Multistep Gastric Carcinogenesis

  2003cited by this paper
• Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer

  2003cited by this paper
• Critical Role of Histone Methylation in Tumor Suppressor Gene Silencing in Colorectal Cancer

  2003cited by this paper
• DNA hypermethylation and histone hypoacetylation of the HLTF gene are associated with reduced expression in gastric carcinoma

  2003cited by this paper
• Reduced Expression of the TSP1 Gene and Its Association with Promoter Hypermethylation in Gastric Carcinoma

  2003cited by this paper
• Epigenetic inactivation of CHFR and sensitivity to microtubule inhibitors in gastric cancer.

  2003cited by this paper
• Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas.

  2003cited by this paper
• DNA methylation analysis: a powerful new tool for lung cancer diagnosis

  2002cited by this paper
• Reactivating the expression of methylation silenced genes in human cancer

  2002cited by this paper
• Distinct promoter hypermethylation of p16INK4a, CDH1, and RAR‐beta in intestinal, diffuse–adherent, and diffuse–scattered type gastric carcinomas

  2002cited by this paper
• Acetylated histone H4 is reduced in human gastric adenomas and carcinomas.

  2002cited by this paper

• The Oncogenic Role of UBXN1 in Gastric Cancer Is Attributed to the METTL16‐Mediated m6A Methylation and Histone Modifications

  2025cites this paper
• DNMT1 promotes the proliferation and migration of gastric cancer cells by inducing microRNA-125a-5p methylation to promote SERPINE1 protein

  2025cites this paper
• Gastric Cancer in the Era of Epigenetics

  2024cites this paper
• Modelling of miRNA-mRNA Network to Identify Gene Signatures with Diagnostic and Prognostic Value in Gastric Cancer: Evidence from In-Silico and In-Vitro Studies.

  2024cites this paper
• Exploring the Complexity of Pan-Cancer: Gene Convergences and in silico Analyses

  2024cites this paper
• Lack of Association Between BsmI and FokI Polymorphisms of the VDR Gene and Sporadic Colorectal Cancer in a Romanian Cohort—A Preliminary Study

  2024cites this paper
• Novel biomarkers for early detection of gastric cancer

  2023cites this paper
• Histone and DNA Methylation as Epigenetic Regulators of DNA Damage Repair in Gastric Cancer and Emerging Therapeutic Opportunities

  2023cites this paper
• Potential biomarkers for the prognosis and treatment of HCC immunotherapy.

  2023cites this paper
• Interaction of ncRNA and Epigenetic Modifications in Gastric Cancer: Focus on Histone Modification

  2022cites this paper
• Dysregulation of let-7c-5p/Tyrosyl-DNA phosphodiesterase 1 axis indicates an unfavorable outcome in gastric cancer

  2022cites this paper
• CRISPR/Cas9 as precision and high-throughput genetic engineering tools in gastrointestinal cancer research and therapy.

  2022cites this paper
• Role of non-coding RNA in immune microenvironment and anticancer therapy of gastric cancer

  2022cites this paper
• Signaling pathways and therapeutic interventions in gastric cancer

  2022cites this paper
• DNA Methylation of HOXA11 Gene as Prognostic Molecular Marker in Human Gastric Adenocarcinoma

  2022cites this paper
• Regulatory function of DNA methylation mediated lncRNAs in gastric cancer

  2022cites this paper
• Current Advances in Coptidis Rhizoma for Gastrointestinal and Other Cancers

  2022cites this paper
• Gastric Cancer: Locoregional Disease

  2021cites this paper
• A predictive model for assessing prognostic risks in gastric cancer patients using gene expression and methylation data

  2021cites this paper
• Development and Validation of a Robust Immune-Related Prognostic Signature for Gastric Cancer

  2021cites this paper
• Methylation and Noncoding RNAs in Gastric Cancer: Everything Is Connected

  2021cites this paper
• Down‐regulation of hsa_circ_0006470 predicts tumor invasion: A new biomarker of gastric cancer

  2021cites this paper
• From Inflammation to Cancer: Role of Genetic Polymorphisms of Inflammatory Pathway Molecules in Gastric Cancer

  2021cites this paper
• Aberrant DNA Methylation-Mediated FOXF2 Dysregulation Is a Prognostic Risk Factor for Gastric Cancer

  2021cites this paper
• Is there a relationship between neural EGFL like 1 (NELL1) promoter hypermethylation and prognosis of gastric cancer?

  2021cites this paper
• Reviewing cancer’s biology: an eclectic approach

  2021cites this paper
• Novel Biomarkers of Gastric Adenocarcinoma: Current Research and Future Perspectives

  2021cites this paper
• Transcriptional and Epigenetic Bioinformatic Analysis of Claudin-9 Regulation in Gastric Cancer

  2021cites this paper
• LETM 1 Promotes Gastric Cancer Cell Proliferation , Migration , and Invasion via the PI 3 K / Akt Signaling Pathway

  2020cites this paper
• Identification of the subtypes of gastric cancer based on DNA methylation and the prediction of prognosis

  2020cites this paper
• Novel therapeutic approaches for gastrointestinal malignancies

  2020cites this paper
• Recent Advancements in Biomarkers and Early Detection of Gastrointestinal Cancers

  2020cites this paper
• LETM1 Promotes Gastric Cancer Cell Proliferation, Migration, and Invasion via the PI3K/Akt Signaling Pathway

  2020cites this paper
• Epigenetic Modifications in Gastric Cancer: Focus on DNA Methylation.

  2020cites this paper
• Relationship between DLEC1 and PBX3 promoter methylation and the risk and prognosis of gastric cancer in peripheral blood leukocytes

  2020cites this paper
• Combined detection of miR-21-5p, miR-30a-3p, miR-30a-5p, miR-155-5p, miR-216a and miR-217 for screening of early heart failure diseases

  2020cites this paper
• Identification of Potential Key Genes Involved in Progression of Gastric Cancer Using Bioinformatics Analysis

  2020cites this paper
• Overview of Early Detection of Gastrointestinal Cancer

  2020cites this paper
• Gastrointestinal adenocarcinoma analysis identifies promoter methylation-based cancer subtypes and signatures

  2020cites this paper
• Epigenetic Variation Analysis Leads to Biomarker Discovery in Gastric Adenocarcinoma

  2020cites this paper
• The Reprimo-Like Gene Is an Epigenetic-Mediated Tumor Suppressor and a Candidate Biomarker for the Non-Invasive Detection of Gastric Cancer

  2020cites this paper
• OGDH mediates the inhibition of SIRT5 on cell proliferation and migration of gastric cancer.

  2019cites this paper
• Recent advances in gastric cancer early diagnosis

  2019cites this paper
• High‐level expression of PRSS3 correlates with metastasis and poor prognosis in patients with gastric cancer

  2019cites this paper
• Fluctuations of epigenetic regulations in human gastric Adenocarcinoma: How does it affect?

  2019cites this paper
• KRT15, INHBA, MATN3, and AGT are aberrantly methylated and differentially expressed in gastric cancer and associated with prognosis.

  2019cites this paper
• A Natural Isoquinoline Alkaloid With Antitumor Activity: Studies of the Biological Activities of Berberine

  2019cites this paper
• [Advances in serum biomarkers for early diagnosis of gastric cancer].

  2019cites this paper
• CMAR_A_223204 10509..10521

  2019cites this paper
• Current Understanding of Circular RNAs in Gastric Cancer

  2019cites this paper
• OTT_A_210376 7513..7525

  2019cites this paper
• Epigenetics mechanisms mediate the miR-125a/BRMS1 axis to regulate invasion and metastasis in gastric cancer

  2019cites this paper
• World Journal of Gastroenterology

  year unknowncites this paper